Option chain shows key data for Climb Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Climb Bio.

Climb Bio (NASDAQ:CLYM) Stock, Option Chain

Climb Bio

Eliem Therapeutics

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Climb Bio Inc

News

Press Releases

Climb Bio to Present at Upcoming Investor Conferences

Management

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

Earnings

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Climb Bio to be Added to the Nasdaq Biotechnology Index

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Climb Bio, Inc. (NASDAQ: CLYM)

Health Care

General

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer

Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates

CLYM

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Atossa Therapeutics

Avalo Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Biomea Fusion

Cabaletta Bio

Caribou Biosciences

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

HilleVax

IO Biotech

Invivyd

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Nkarta

OncoCyte

Regulus Therapeutics

TScan Therapeutics

Vigil Neuroscience

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

XBiotech

Exicure

Zura Bio Limited - Class A Ordinary shares

Comments

Climb Bio

Climb Bio (CLYM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga